AI CAPITAL INTELLIGENCE
OpenEvidence · Series D · USD 250,000,000 · 2026-01-21
Financing facts, at a glance
OpenEvidence: financing disclosed on 2026-01-21, Series D, USD 250,000,000. Named investors: Thrive Capital, DST Global. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
Original source 1 · Original source 2 · Original source 3 · Original source 4
OpenEvidence is recorded in the Industry AI / Healthcare & clinical AI segment. The disclosed financing is Series D, with an amount of USD 250,000,000. Named investors include Thrive Capital, DST Global.
- Disclosed company name
- OpenEvidence
- Disclosure date
- 2026-01-21
- Round
- Series D
- Financing amount
- USD 250,000,000
- Market coverage
- Outside China
- Sector
- Industry AI / Healthcare & clinical AI
- Product form
- Enterprise software
Disclosed investors
Thrive Capital, DST Global
Original sources
- Source 1 · bydrug.pharmcube.com
- Source 2 · tracxn.com
- Source 3 · research.contrary.com
- Source 4 · www.prnewswire.com
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.